Compare Informasi Teknologi Indonesia Tbk. (JATI) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Informasi Teknologi Indonesia Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Informasi Teknologi Indonesia Tbk. trades at Rp111 (market cap 365.4B, 13.91M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Informasi Teknologi Indonesia Tbk. is far larger — about 3.5× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| JATI | SCPI | |
|---|---|---|
Market Cap | 365.4B | 104.4B |
Volume | 13.91M | — |
Lot | 139.12K | — |
Turnover | 1.54B | — |
Average Price | 110.85 | — |
Value | 1.54B | — |
Indicative Equilibrium Price | 111 | — |
Indicative Equilibrium Volume | 339 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Informasi Teknologi Indonesia Tbk.
PT Informasi Teknologi Indonesia Tbk (the “Company”) was established based on Deed No. 127 dated April 11, 2002 of Iman Immanuel Sinaga, S.H., CN, a substitute notary of Dr. Irawan Soerodjo, S.H., M,S.i. The Company started its commercial operations in 2002. The direct parent entity and ultimate parent entity of the Company are PT Jati Piranti Solusindo and PT Indivara Sejahtera Mandiri.
Read more on JATI →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
